HomeBGLC • NASDAQ
add
BioNexus Gene Lab Corp
Previous close
$2.27
Day range
$2.21 - $2.22
Year range
$1.92 - $15.60
Market cap
5.37M USD
Avg Volume
4.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 483.76K | -80.83% |
Operating expense | 1.12M | 43.61% |
Net income | -1.04M | -197.46% |
Net profit margin | -214.18 | -1,452.03% |
Earnings per share | — | — |
EBITDA | -1.09M | -149.06% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.04M | -7.72% |
Total assets | 9.25M | -11.32% |
Total liabilities | 637.86K | -69.78% |
Total equity | 8.61M | — |
Shares outstanding | 2.42M | — |
Price to book | 0.64 | — |
Return on assets | -33.18% | — |
Return on capital | -35.23% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.04M | -197.46% |
Cash from operations | 961.06K | 338.43% |
Cash from investing | -5.72K | -101.03% |
Cash from financing | 266.54K | 287.20% |
Net change in cash | 1.13M | 409.57% |
Free cash flow | 1.30M | 383.97% |
About
Founded
2017
Website
Employees
19
